ライフサイエンスコーパス: gestational hypertension

1 tensive disorder of pregnancy (preeclampsia, gestational hypertension).

2 an HDP (487 [6.5%] preeclampsia, 545 [7.3%] gestational hypertension).

3 may also occur, leading to preeclampsia and gestational hypertension.

4 uced risk of HDP, including preeclampsia and gestational hypertension.

5 ancy was associated with an elevated risk of gestational hypertension.

6 rtension who did not develop preeclampsia or gestational hypertension.

7 preterm preeclampsia, term preeclampsia, and gestational hypertension.

8 th term preeclampsia and not associated with gestational hypertension.

9 omen with preeclampsia, including those with gestational hypertension.

10 cholesterol levels and 2) family history of gestational hypertension.

11 fore and after the onset of preeclampsia and gestational hypertension.

12 sity, smoking, hyperlipidemia, migraine, and gestational hypertension.

13 diabetes treatment also reduced the risk for gestational hypertension.

14 risk for preeclampsia and decreased risk for gestational hypertension.

15 nly baseline BP and BMI were associated with gestational hypertension.

16 taining multivitamins may reduce the risk of gestational hypertension.

17 ation between folic acid supplementation and gestational hypertension.

18 guidelines for the definition of chronic and gestational hypertension.

19 ere: pre-eclampsia, 1.78 (95% CI 1.52-2.08); gestational hypertension 1.76 (1.39-2.23); gestational d

20 .3%, made up of chronic hypertension (5.9%), gestational hypertension (1.3%), and pre-eclampsia (3%),

21 rated a significantly decreased incidence of gestational hypertension (1.6% versus 8.5%; P < 0.01), b

22 ssociated with preeclampsia/eclampsia and/or gestational hypertension, 12 of which are new (for examp

23 at term (at > or =37 weeks), 120 women with gestational hypertension, 120 normotensive women who del

24 chronic hypertension and no preeclampsia or gestational hypertension (165.8 [95% CI, 160.6-171.2] ca

25 9 621 pregnancies) and a 13.8% prevalence of gestational hypertension (18 998 pregnancies).

26 sful pregnancies, with the most common being gestational hypertension (2 [14%]), cervical insufficien

27 % CI, 168.0-225.2] cases per 10,000 births), gestational hypertension (312.7 [95% CI, 281.6-346.1] ca

28 uency (mean APC per year) of preeclampsia or gestational hypertension (4.2% [95% CI, 3.3% to 5.2%]),

29 ed miscarriage (13.3%), preeclampsia (4.4%), gestational hypertension (4.4%), proteinuria (4.4%), and

30 Common associated conditions were gestational hypertension (43%), tocolytic therapy (19%),

31 eeclampsia, 75.3% [95% CI, 73.8%-76.2%]; and gestational hypertension, 75.1% [95% CI, 72.9%-77.1%]).

32 itions (gestational diabetes, 10.3% vs 9.9%; gestational hypertension, 8.7% vs 6.1%; preeclampsia, 6.

33 chronic hypertension and no preeclampsia or gestational hypertension) adjusted for clinical, sociode

34 .75-2.48]) compared with full-term delivery; gestational hypertension (aHR, 1.09 [0.97-1.22]); preecl

35 1.4% (95% CI 0.9% to 2.0%) pregnancies, and gestational hypertension alone was reported in 7.4% (95%

36 Most women in this study presented with gestational hypertension amenable to surveillance and ti

37 were observed for history of preeclampsia or gestational hypertension among women with low predicted

38 lthood: RR was 2.04 (95% CI: 0.93, 4.47) for gestational hypertension and 1.11 (95% CI: 0.63, 1.93) f

39 ore common among donors (odds ratio, 2.5 for gestational hypertension and 2.4 for preeclampsia).

40 %) of the increased risk of CVD conferred by gestational hypertension and 57% of the risk among women

41 underlie epidemiologic associations between gestational hypertension and a higher risk of hypertensi

42 preterm premature rupture of the membranes, gestational hypertension and gestational diabetes.

43 reterm labor, gestational diabetes mellitus, gestational hypertension and gestational hypothyroidism.

44 The study focused on gestational hypertension and pre-eclampsia within the te

45 ive disorders of pregnancy (HDPs), including gestational hypertension and pre-eclampsia, are common o

46 hood were associated with increased risks of gestational hypertension and pre-eclampsia, whereas norm

47 g obesity) is an established risk factor for gestational hypertension and pre-eclampsia.

48 idney donation seems to elevate the risks of gestational hypertension and pre-eclampsia.

49 childhood to adulthood were associated with gestational hypertension and pre-eclampsia.

50 women, and to be even greater in women with gestational hypertension and preeclampsia at term.

51 The primary outcome was the RR of gestational hypertension and preeclampsia between pregna

52 mend follow-up after delivery for women with gestational hypertension and preeclampsia for their incr

53 History of gestational hypertension and preeclampsia were both sign

54 The risks of gestational hypertension and preeclampsia were compared

55 sive disorders of pregnancy (HDP), including gestational hypertension and preeclampsia, are associate

56 For gestational hypertension and preeclampsia, we estimated

57 sive disorders of pregnancy (HDP), including gestational hypertension and preeclampsia.

58 egnant women with OSA may reduce the risk of gestational hypertension and preeclampsia.

59 ntify women who are at an increased risk for gestational hypertension and preeclampsia.

60 reuptake inhibitors (SSRIs) on the risks of gestational hypertension and preeclampsia.

61 rimary outcome was pre-eclampsia, defined as gestational hypertension and proteinuria.

62 stem pregnancy complication characterized by gestational hypertension and proteinuria.

63 ed hypertension (preeclampsia, eclampsia, or gestational hypertension), and neonatal lean body mass.

64 chronic hypertension with preeclampsia, (4) gestational hypertension, and (5) no chronic hypertensio

65 f participants was 32.6 (5.0) years, 40% had gestational hypertension, and 60% had preeclampsia.

66 a, 24.9% (95% CI, 22.5%-27.5%) of women with gestational hypertension, and 76.7% (95% CI, 76.3%-77.1%

67 protective against preeclampsia without pre gestational hypertension, and even then principally amon

68 Preeclampsia, gestational hypertension, and gestational diabetes, the

69 pregnancy and include chronic hypertension, gestational hypertension, and pre-eclampsia.

70 summary statistics for exposures of any HDP, gestational hypertension, and preeclampsia or eclampsia.

71 disorders of pregnancy-chronic hypertension, gestational hypertension, and preeclampsia-are uniquely

72 ional diabetes, pregestational hypertension, gestational hypertension, and preeclampsia.

73 The HRs for preeclampsia or eclampsia, gestational hypertension, and pregestational hypertensio

74 Pre-eclampsia, gestational hypertension, and small-for-gestational-age

75 es mellitus (aOR = 1.07, 95%CI = 0.98-1.16), gestational hypertension (aOR = 0.99, 95%CI = 0.89-1.11)

76 Women who develop gestational hypertension are at increased risk of advers

77 Preeclampsia and gestational hypertension are common pregnancy complicati

78 Preeclampsia and gestational hypertension are leading complications of pr

79 pregnancy (HDPs) (preeclampsia/eclampsia and gestational hypertension) are a leading cause of materna

80 rth, low birth weight, gestational diabetes, gestational hypertension, assisted reproductive technolo

81 WILL randomised women with chronic or gestational hypertension at 36 to 37 weeks and a singlet

82 , -0.513; 95% CI, -0.857 to -0.170), but not gestational hypertension (beta, 0.003; 95% CI, -0.338 to

83 Among pregnant individuals with chronic or gestational hypertension, blood pressure self-monitoring

84 sed rate of CVD for preeclampsia but 84% for gestational hypertension (both P < 0.0001).

85 d not observe a significant association with gestational hypertension, cesarean births, or newborn he

86 iation between GWG interventions and risk of gestational hypertension, cesarean delivery, or preeclam

87 y body mass index, diabetes (preexisting and gestational), hypertension (chronic and gestational), bi

88 HDP subtypes included gestational hypertension, chronic hypertension, preeclam

89 the chronic hypertension cohort and 1 in the gestational hypertension cohort).

90 In the gestational hypertension cohort, there was also no signi

91 iated with reduced rates of preeclampsia and gestational hypertension (combined rates for the two con

92 ilatation was higher during a pregnancy with gestational hypertension compared with preeclampsia (P=0

93 Chronic or gestational hypertension complicates approximately 7% of

94 Gestational hypertension develops differently, with a hy

95 variate-adjusted relative risk of developing gestational hypertension during the month after folic ac

96 (enrolled up to 37 weeks' gestation) or with gestational hypertension (enrolled between 20 and 37 wee

97 HDP for ischemic stroke, late menopause and gestational hypertension for hemorrhagic stroke, and oop

98 ore of the following outcomes: preeclampsia, gestational hypertension, gestational diabetes, cesarean

99 Secondary outcomes included gestational hypertension, gestational diabetes, depressi

100 posite APO outcome, including pre-eclampsia, gestational hypertension, gestational diabetes, intraute

101 of the following: preeclampsia or eclampsia, gestational hypertension, gestational diabetes, preterm

102 The incidence of gestational hypertension (GH) and pre-eclampsia (PE) is

103 subcategories based on the severity of HDP: gestational hypertension (GH) and preeclampsia and eclam

104 hocardiography in pregnancies complicated by gestational hypertension (GH) and preeclampsia.

105 nsion in the general population, but data on gestational hypertension (GH) are limited.

106 n of gestational diabetes mellitus (GDM) and gestational hypertension (GH) with cardiometabolic disea

107 m healthy pregnant women (HP), subjects with gestational hypertension (GH), and PE patients on global

108 tion between vitamin D, PTH and calcium with gestational hypertension (GH), pre-eclampsia (PE), caesa

109 cases of pre-eclampsia (PE) and 33 cases of gestational hypertension (GH); 53 cases of PTB; and 109

110 ny hypertensive disorder in pregnancy (HDP) (gestational hypertension [GH], preeclampsia, or eclampsi

111 y donors have increased risk of postdonation gestational hypertension (gHTN) and preeclampsia.

112 In the general population, gestational hypertension (GHtn), preeclampsia/eclampsia,

113 the risks of HDP, including preeclampsia and gestational hypertension (GHTN).

114 rs of pregnancy, including pre-eclampsia and gestational hypertension (GHTN).

115 .17 [95% CI, 1.003-1.36]; P = .046), and the gestational hypertension group (aRR, 1.78 [95% CI 1.60-1

116 chronic hypertension and no preeclampsia or gestational hypertension group, risks of SMM were signif

117 clampsia without chronic hypertension, while gestational hypertension had intermediate rates of SMM.

118 Women with gestational hypertension had the highest rate of initiat

119 o were reclassified with chronic rather than gestational hypertension had the highest risk of develop

120 eclampsia (HR: 1.72; 95% CI: 1.42-2.10) than gestational hypertension (HR: 1.41; 95% CI: 1.03-1.93).

121 ses and 703,117 control individuals and with gestational hypertension in 11,027 cases and 412,788 con

122 Gestational diabetes occurred in 11.4%, gestational hypertension in 9.5%, and preeclampsia in 12

123 e evaluated its role in normal pregnancy and gestational hypertension in a mouse model.

124 was to compare the risk of preeclampsia and gestational hypertension in a prospective cohort of norm

125 es that predicted preeclampsia/eclampsia and gestational hypertension in external cohorts, independen

126 However, comparison with gestational hypertension indicates that additional facto

127 , primary cesarean delivery, preeclampsia or gestational hypertension, intensive care unit (ICU) admi

128 tic liability to pre-eclampsia/eclampsia and gestational hypertension is associated with CVD risk fac

129 line increased the prevalence of chronic and gestational hypertension, markedly improved the appropri

130 n gestation at entry, 20 weeks) and 396 with gestational hypertension (mean age, 34 years; mean gesta

131 Women with gestational hypertension (n = 11 133), preeclampsia (n =

132 on risk of de novo preeclampsia (n = 44) and gestational hypertension (n = 172) among women recruited

133 d as preeclampsia or eclampsia (n = 68,387), gestational hypertension (n = 18,603), and pregestationa

134 Women with gestational hypertension (n = 496) and pre-eclampsia (n

135 s and 30 with HDP: pre-eclampsia (n = 21) or gestational hypertension (n = 9).

136 (n=1,180), mild preeclampsia (n=5,468), and gestational hypertension (n=8,943).

137 7 person-years of follow-up among women with gestational hypertension, n = 40 cardiomyopathy events;

138 Gestational hypertension occurred during 23% of pregnanc

139 s, after MBS births had fewer occurrences of gestational hypertension (odds ratio [OR], 0.16; 95% CI,

140 tation who had nonproteinuric preexisting or gestational hypertension, office diastolic blood pressur

141 Of 2,100 women, 204 (9.7%) reported gestational hypertension (onset after the 20th week of g

142 e and outcomes of HDP (chronic hypertension, gestational hypertension or pre-eclampsia) were assessed

143 The occurrence of HDPs, either gestational hypertension or pre-eclampsia, was associate

144 An occurrence of HDPs, either gestational hypertension or pre-eclampsia, was associate

145 ies in donors may incur attributable risk of gestational hypertension or preeclampsia (11% versus 5%

146 Gestational hypertension or preeclampsia (vs normal bloo

147 ounts were higher in women with a history of gestational hypertension or preeclampsia compared to oth

148 defined by maternal diagnosis of chronic or gestational hypertension or preeclampsia during pregnanc

149 Gestational hypertension or preeclampsia was more common

150 Gestational hypertension or preeclampsia was more likely

151 rates of de novo hypertension in pregnancy (gestational hypertension or preeclampsia) and prepregnan

152 as new-onset hypertension during pregnancy (gestational hypertension or preeclampsia).

153 elative risk, 1.04; 97.5% CI, 0.88 to 1.23); gestational hypertension or preeclampsia, 13.6% and 13.5

154 r hand nerve palsy related to birth injury), gestational hypertension or preeclampsia, and primary ce

155 primary outcome was a hospital diagnosis of gestational hypertension or preeclampsia.

156 omen with HDP were classified into low-risk (gestational hypertension or term preeclampsia followed b

157 (odds ratio [OR] 1.48, 1.29-1.70), maternal gestational hypertension (OR 1.37, 1.21-1.54), maternal

158 The risk of CVD was highest in women with gestational hypertension (OR 1.7; 95% ICI, 1.3-2.2), pre

159 .06-1.27), but they were not associated with gestational hypertension (OR, 1.07; 95% CI, 0.92-1.25).

160 .002); this association was evident for both gestational hypertension (OR, 1.08; 95% CI, 1.00-1.17; P

161 Lastly, the adjusted odds of gestational hypertension (OR, 1.08; 95% CI, 1.06-1.11),

162 ink use was associated with a higher risk of gestational hypertension (OR, 1.60; 95% CI, 1.12-2.29).

163 preeclampsia (OR: 4.68; 95% CI: 2.42-9.07), gestational hypertension (OR: 2.42; 95% CI: 1.25-4.67),

164 preeclampsia (OR=1.5, 95% CI: 1.3, 1.8), and gestational hypertension (OR=1.4, 95% CI: 1.2, 1.6).

165 women who later developed term preeclampsia, gestational hypertension, or normotensive pregnancy.

166 Preterm birth combined with hemorrhage, gestational hypertension, or preexisting hypertension id

167 m preeclampsia: OR, 0.98; 95% CI, 0.88-1.10; gestational hypertension: OR, 1.13; 95% CI, 0.92-1.38).

168 nsive disorders (P = .02 for interaction for gestational hypertension; P = .04 for interaction for an

169 gestational (>=20 weeks); pre-eclampsia was gestational hypertension plus proteinuria or a pre-eclam

170 rs classified pregnancies into normotensive, gestational hypertension, pre-eclampsia, eclampsia, pre-

171 idence intervals (CIs) for associations with gestational hypertension, preeclampsia with severe featu

172 Gestational hypertension, preeclampsia, and eclampsia ar

173 In this study, gestational hypertension, preeclampsia, and eclampsia we

174 Gestational hypertension, preeclampsia, and eclampsia.

175 Three pregnancy conditions were examined: gestational hypertension, preeclampsia, and gestational

176 Gestational diabetes (GDM), gestational hypertension, preeclampsia, and preterm deli

177 Maternal (gestational diabetes, gestational hypertension, preeclampsia, cesarean deliver

178 Hypertensive disorders (gestational hypertension, preeclampsia, chronic hyperten

179 recipient, transplant, and fetus, including gestational hypertension, preeclampsia, gestational diab

180 ertensive disorders of pregnancy, defined as gestational hypertension, preeclampsia, or eclampsia, re

181 gnancy-specific stroke risk factors, such as gestational hypertension, preeclampsia, or gestational d

182 luding pregnancy loss, gestational diabetes, gestational hypertension, preeclampsia, or preterm birth

183 estational weight gain (GWG), pre-eclampsia, gestational hypertension, preterm birth, gestational age

184 pregnancy outcomes, including preeclampsia, gestational hypertension, preterm delivery, small-for-ge

185 rtension by age, sex, birth weight, maternal gestational hypertension, prior comorbidities (chronic k

186 chronic hypertension and no preeclampsia or gestational hypertension (reference group).

187 regnancy (severe or moderate preeclampsia or gestational hypertension) registered in the National Pat

188 .3; P = 0.01), while their relative risk for gestational hypertension remained significantly decrease

189 we observed that most women with chronic or gestational hypertension required labour induction, and

190 ing pregnancy complicated by preeclampsia or gestational hypertension, requiring antihypertensive med

191 years of age or older, with preeclampsia or gestational hypertension, requiring antihypertensives on

192 tic liability to pre-eclampsia/eclampsia and gestational hypertension, respectively.

193 . Q1: 0.19 (0.05, 0.65), P-trend = 0.01] and gestational hypertension risk; AHEI score reported at 24

194 non-CPAP use) groups in reducing the risk of gestational hypertension (RR, 0.65; 95% CI, 0.47-0.89; P

195 nt when examining preeclampsia/eclampsia and gestational hypertension separately.

196 Analyses of gestational hypertension showed no indication of a prote

197 cidence of any secondary outcomes, including gestational hypertension, stillbirth, abruption, deliver

198 4% in both mild preeclamptics and those with gestational hypertension) than in controls (2.7%).

199 The aHR for gestational hypertension was 1.27 (95% CI, 1.12-1.45), 1

200 percentile of the CDC BMI reference), RR for gestational hypertension was 1.66 (95% CI: 1.42, 1.94) a

201 Gestational hypertension was associated with increased r

202 Gestational hypertension was defined as incident hyperte

203 At first presentation with elevated BP, gestational hypertension was most common diagnosis (part

204 Among women who received treatment, gestational hypertension was present in 13.1% of the 107

205 Gestational hypertension was present in 9.0% of the 5,53

206 Gestational hypertension was related to heart failure (a

207 Gestational hypertension was reported by 9.4% of partici

208 ious pregnancy, but not term preeclampsia or gestational hypertension, was associated with offspring

209 al timing of birth for women with chronic or gestational hypertension who reach term and remain well.

210 There was strong evidence of a high risk of gestational hypertension with deflation compared with co

211 Some evidence of a higher risk of gestational hypertension with deflation than with inflat

212 point was pre-eclampsia, which we defined as gestational hypertension with proteinuria.